NCT06690736View on ClinicalTrials.gov

Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

October 1, 2027

Study Completion Date

October 1, 2027

Conditions
CXCR4-related DiseaseTumorPositron Emission TomographyMetastasis
Interventions
DIAGNOSTIC_TEST

CXCR4 PET/CT Imaging

Each subject receive a single intravenous injection of 68Ga/18F-Pentixafor/Pentixather, and undergo PET/CT imaging within the specificed time.

Trial Locations (1)

300052

RECRUITING

Tianjin Medical University General Hospital, Tianjin

All Listed Sponsors
collaborator

Tianjin Medical University General Hospital

OTHER

lead

Tianjin Medical University

OTHER